World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
34261
World Ranking
12556
National Ranking
6426

Overview

Mark C. Gebhardt is affiliated with Harvard Medical School in the United States and has contributed extensively to the field of medicine, with a particular focus on surgery. Their research encompasses a broad range of subfields including pulmonary and respiratory medicine, public health, environmental and occupational health, cardiology and cardiovascular medicine, and rheumatology.

The primary topics of Gebhardt's work include sarcoma diagnosis and treatment, cardiac, anesthesia and surgical outcomes, bone tumor diagnosis and treatments, diversity and career in medicine, meta-analysis and systematic reviews, management of metastatic bone disease, and anesthesia and pain management.

Gebhardt has published numerous papers in prominent venues. Frequent publication venues include:

  • Clinical Orthopaedics and Related Research
  • UNC Libraries
  • Cancer
  • Journal of Pediatric Orthopaedics
  • JBJS Open Access

Recent papers authored or coauthored by Gebhardt cover a diverse range of topics and years of publication. Notable works include:

  • Editorial: What CORR ® Seeks From Papers About New Implants and Techniques, 2022, Clinical Orthopaedics and Related Research
  • Complete tumor necrosis after neoadjuvant chemotherapy defines good responders in patients with Ewing sarcoma, 2022, Cancer
  • Editorial: Opposites Attract at CORR®-Machine Learning and Qualitative Research, 2020, Clinical Orthopaedics and Related Research
  • What Are Risk Factors for and Outcomes of Late Amputation After Treatment for Lower Extremity Sarcoma: A Childhood Cancer Survivor Study Report, 2022, Clinical Orthopaedics and Related Research
  • Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Chest Wall: Impact of Initial Versus Delayed Resection on Tumor Margins, Survival, and Use of Radiation Therapy, 2021, UNC Libraries

Collaborations represent an important component of Gebhardt's research activity. Frequent coauthors include Seth S. Leopold, Terence J. Gioe, Paul Manner, Raphaël Porcher, and Clare M. Rimnac, each having collaborated on multiple publications.

Best Publications

  • A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system.

    William F. Enneking;William Dunham;Mark C. Gebhardt;Martin Malawar

  • Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.

    Holcombe E Grier;Mark D Krailo;Nancy J Tarbell;Michael P Link

  • p53 functions as a cell cycle control protein in osteosarcomas.

    L Diller;J Kassel;C E Nelson;M A Gryka

  • Long-term results of allograft replacement in the management of bone tumors.

    Henry Mankin;Mark Gebhardt;L. Jennings;Dempsey Springfield

  • Biology and Therapeutic Advances for Pediatric Osteosarcoma

    Neyssa Marina;Mark Gebhardt;Lisa Teot;Richard Gorlick

  • Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

    Paul A. Meyers;Cindy L. Schwartz;Mark D. Krailo;John H. Healey

  • Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate

    Paul A. Meyers;Cindy L. Schwartz;Mark Krailo;Eugenie S. Kleinerman

  • Percutaneous radiofrequency coagulation of osteoid osteoma compared with operative treatment.

    Daniel Rosenthal;Francis Hornicek;Michael Wolfe;L. Jennings

  • Infection in bone allografts. Incidence, nature, and treatment.

    C F Lord;M C Gebhardt;W W Tomford;H J Mankin

  • Osteoid osteoma: percutaneous treatment with radiofrequency energy.

    Daniel I Rosenthal;Francis J Hornicek;Martin Torriani;Mark C Gebhardt

  • Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

    Neyssa M Marina;Sigbjørn Smeland;Stefan S Bielack;Mark Bernstein

  • Chondrosarcoma of Bone: An Assessment of Outcome*

    Francis Y. Lee;Henry J. Mankin;Gertrude Fondren;Mark C. Gebhardt

  • Recurrence of giant-cell tumors of the long bones after curettage and packing with cement.

    Richard O'Donnell;Dempsey Springfield;Haresh Motwani;John Ready

  • Aneurysmal Bone Cyst: A Review of 150 Patients

    Henry J. Mankin;Francis J. Hornicek;Eduardo Ortiz-Cruz;Jorge Villafuerte

  • Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

    Sigbjørn Smeland;Stefan S. Bielack;Jeremy Whelan;Mark Bernstein

  • Fractures of allografts. Frequency, treatment, and end-results.

    B H Berrey;C F Lord;M C Gebhardt;H J Mankin

  • Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

    Stefan S. Bielack;Sigbjørn Smeland;Jeremy S. Whelan;Neyssa Marina

  • USP6 and CDH11 oncogenes identify the neoplastic cell in primary aneurysmal bone cysts and are absent in so-called secondary aneurysmal bone cysts.

    Andre M. Oliveira;Andre M. Oliveira;Antonio R. Perez-Atayde;Carrie Y. Inwards;Fabiola Medeiros

  • Presurgical Chemotherapy Compared With Immediate Surgery and Adjuvant Chemotherapy for Nonmetastatic Osteosarcoma: Pediatric Oncology Group Study POG-8651

    Allen M. Goorin;Douglas J. Schwartzentruber;Meenakshi Devidas;Mark C. Gebhardt

  • Osteoid osteoma: Percutaneous radio-frequency ablation

    Daniel I. Rosenthal;Dempsey S. Springfield;Mark C. Gebhardt;Andrew E. Rosenberg

Frequent Co-Authors

Henry J. Mankin
Henry J. Mankin Harvard University
Francis J. Hornicek
Francis J. Hornicek University of Miami
Holcombe E. Grier
Holcombe E. Grier Harvard University
Andrew E. Rosenberg
Andrew E. Rosenberg University of Miami
Antonio R. Perez-Atayde
Antonio R. Perez-Atayde Boston Children's Hospital
Mark Krailo
Mark Krailo University of Southern California
Daniel I. Rosenthal
Daniel I. Rosenthal Harvard University
Herman D. Suit
Herman D. Suit Harvard University
Paul A. Meyers
Paul A. Meyers Memorial Sloan Kettering Cancer Center
Nancy J. Tarbell
Nancy J. Tarbell Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medicine, a growing number of online degree options offer flexible and accelerated routes to a healthcare career. Programs like the shortest online dnp program allow qualified nurses to quickly advance their education and job prospects. Additionally, candidates with busy schedules or who seek alternatives to in-person experiences can opt for online dnp programs without clinicals, eliminating the need for traditional on-site placements.

Those beginning their healthcare journey may consider an accelerated lpn program, which provides a rapid pathway into nursing practice, often in under a year. For those looking to specialize, advanced programs such as online psych np programs enable registered nurses to become Psychiatric Mental Health Nurse Practitioners (PMHNP), a field with growing demand in the US.

These diverse online pathways offer flexibility and accessibility, helping students shape their medical careers to suit personal goals and evolving industry needs.

Best Scientists Citing Mark C. Gebhardt

Trending Scientists

Recently Published Articles